Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion

Journal of Cerebral Blood Flow and Metabolism

Volumn 27, Issue 4, 2007, Pages 719-728

  Fan, Yongfeng ^a   Shi, Langfeng ^a   Gu, Yuehua ^a   Zhao, Yanxin ^a   Xie, Jun ^b   Qiao, Jian ^a   Yang, Guo Yuan ^c,d   Wang, Yang ^e   Lu, Chuan Zhen ^a,e  

^a FUDAN UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Blood brain barrier; Brain; Calbindin D 28k; Focal ischemia; Protein transduction

Indexed keywords

CALBINDIN; CASPASE 3; GLUCOSE; HYBRID PROTEIN; N METHYL DEXTRO ASPARTIC ACID; OXYGEN; PROTEIN TRANSDUCTION DOMAIN CALBINDIN D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SLICE; CALCIUM CELL LEVEL; CELL DEATH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ASSAY; ESCHERICHIA COLI; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; CALCIUM; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSOL; ESCHERICHIA COLI; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; HIPPOCAMPUS; HYPOXIA, BRAIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RECOMBINANT PROTEINS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 33947541241     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600373     Document Type: Article

References (54)

1. Abdel-Hamid KM, Tymianski M (1997) Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J Neurosci 17:3538-53
2. Airaksinen MS, Thoenen H, Meyer M (1997) Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur J Neurosci 9:120-7
3. 2+ channel blocker omega-agatoxin IVA protects against brain injury after focal ischemia in rats. Brain Res 776:140-5
4. Asoh S, Mori T, Nagai S, Yamagata K, Nishimaki K, Miyato Y, Shidara Y, Ohta S (2005) Zonal necrosis prevented by transduction of the artificial anti-death FNK protein. Cell Death Differ 12:384-94
5. Baimbridge KG, Celio MR, Rogers JH (1992) Calciumbinding proteins in the nervous system. Trends Neurosci 15:303-8
6. Beerens AM, Al Hadithy AF, Rots MG, Haisma HJ (2003) Protein transduction domains and their utility in gene therapy. Curr Gene Ther 3:486-94
7. Bellet-Amalric E, Blaudez D, Desbat B, Graner F, Gauthier F, Renault A (2000) Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer, studied by ellipsometry and PM-IRRAS at the air-water interface. Biochim Biophys Acta 1467:131-43
8. Bellido T, Huening M, Raval-Pandya M, Manolagas SC, Christakos S (2000) Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J Biol Chem 275:26328-32
9. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-29
10. Bouilleret V, Schwaller B, Schurmans S, Celio MR, Fritschy JM (2000) Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 97:47-58
11. Cai SR, Xu G, Becker-Hapak M, Ma M, Dowdy SF, McLeod HL (2006) The kinetics and tissue distribution of protein transduction in mice. Eur J Pharm Sci 27:311-9
12. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J (2002) In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 22:5423-31
13. Chen JLY, Wang L, Zhang Z, Lu D, Lu M, Chopp M (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-11
14. 2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res 97:1009-17
15. D'Orlando C, Celio MR, Schwaller B (2002) Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 945:181-90
16. D'Orlando C, Fellay B, Schwaller B, Salicio V, Bloc A, Gotzos V, Celio MR (2001) Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res 909:145-58
17. Dietz GP, Bahr M (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol Cell Neurosci 27:85-131
18. Fan YF, Lu CZ, Xie J, Zhao YX, Yang GY (2006) Apoptosis inhibition in ischemic brain by intraperitoneal PTDBIR3-RING (XIAP). Neurochem Int 48:50-9
19. Geula C, Nagykery N, Wu CK, Bu J (2003) Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to plaques and tangles. J Neuropathol Exp Neurol 62:605-16
20. Guo Q, Christakos S, Robinson N, Mattson MP (1998) Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA 95:3227-32
21. Heizmann CW, Braun K (1992) Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 15:259-64
22. Hwang IK, Kang TC, Lee JC, Park SK, An SJ, Lee IS, Lee YB, Sohn HS, Kang JH, Choi SY, Won MH (2003) Chronological alterations of calbindin D-28k immunoreactivity in the gerbil main olfactory bulb after ischemic insult. Brain Res 971:250-4
23. Jeon HK, Jin HS, Lee DH, Choi WS, Moon CK, Oh YJ, Lee TH (2004) Proteome analysis associated with cadmium adaptation in U937 cells: identification of calbindin-D28k as a secondary cadmium-responsive protein that confers resistance to cadmium-induced apoptosis. J Biol Chem 279:31575-83
24. Joliot A, Prochiantz A (2004) Transduction peptides: from technology to physiology. Nat Cell Biol 6:189-96
25. Kametsu Y, Osuga S, Hakim AM (2003) Apoptosis occurs in the penumbra zone during short-duration focal ischemia in the rat. J Cereb Blood Flow Metab 23:416-22
26. Kilic U, Kilic E, Dietz GP, Bahr M (2003) Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 34:1304-10
27. Kiyama H, Seto-Ohshima A, Emson PC (1990) Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease. Brain Res 525:209-14
28. 2+ channel antagonists and neuroprotection from cerebral ischemia. Eur J Pharmacol 363:1-15
29. Kume T, Nishikawa H, Taguchi R, Hashino A, Katsuki H, Kaneko S, Minami M, Satoh M, Akaike A (2002) Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro. Eur J Pharmacol 455:91-100
30. Lee JC, Hwang IK, Yoo KY, Jung JY, Cho JH, Moon SM, Kang TC, Kim WK, Kim YS, Won MH (2005) Calbindin D-28k is expressed in the microvascular basal lamina in the ventral horn at early time after transient spinal cord ischemia in the rabbit. Brain Res 1047:123-8
31. Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399:A7-14
32. Leifert JA, Harkins S, Whitton JL (2002) Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther 9:1422-8
33. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
34. Mao S (1994) Conjugation of fluorochromes to antibodies. Methods Mol Biol 34:43-7
35. Meier TJ, Ho DY, Park TS, Sapolsky RM (1998) Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide. J Neurochem 71:1013-23
36. 2+ exchanger and AKT. J Biol Chem 280:38505-12
37. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001-11
38. Noguchi H, Matsumoto S (2006) Protein transduction technology: a novel therapeutic perspective. Acta Med Okayama 60:1-11
39. Parkash J, Chaudhry MA, Amer AS, Christakos S, Rhoten WB (2002) Intracellular calcium ion response to glucose in beta-cells of calbindin-D28k nullmutant mice and in betaHC13 cells overexpressing calbindin-D28k. Endocrine 18:221-9
40. Perez-Pinzon MA, Yenari MA, Sun GH, Kunis DM, Steinberg GK (1997) SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits. J Neurol Sci 153:25-31
41. Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S (2001) Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 142:3649-55
42. Rusnati M, Tanghetti E, Urbinati C, Tulipano G, Marchesini S, Ziche M, Presta M (1999) Interaction of fibro blast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell 10:313-27
43. Scheller A, Oehlke J, Wiesner B, Dathe M, Krause E, Beyermann M, Melzig M, Bienert M (1999) Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci 5:185-94
44. Schneider C, Sepp-Lorenzino L, Nimmesgern E, Ouerfelli O, Danishefsky S, Rosen N, Hartl FU (1996) Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc Natl Acad Sci USA 93:14536-41
45. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-72
46. Simic G, Mrzljak L, Fucic A, Winblad B, Lovric H, Kostovic I (1999) Nucleus subputaminalis (Ayala): the still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area. Neuroscience 89:73-89
47. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-82
48. Wang L, Chuan-Zhen L, Qiang D, Jian Q, Hui-Min R, Bao-Guo X (2004) Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats. Brain Res 1015:175-80
49. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1-33
50. 2+ release events associated with the nuclei in adult cardiac myocytes. Circ Res 96:82-90
51. Yenari MA, Minami M, Sun GH, Meier TJ, Kunis DM, McLaughlin JR, Ho DY, Sapolsky RM, Steinberg GK (2001) Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 32:1028-35
52. Zhang RL, Lu CZ, Ren HM, Xiao BG (2003) Metabolic changes of arachidonic acid after cerebral ischemia-reperfusion in diabetic rats. Exp Neurol 184:746-52
53. Ziegler A, Seelig J (2004) Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 86:254-63
54. Zipfel GJ, Lee JM, Choi DW (1999) Reducing calcium overload in the ischemic brain. N Engl J Med 341:1543-4